How do we implement pathogen reduction technology, while maintaining an adequate platelet inventory for our patients?-Reference-Cited by-同舟云学术

How do we implement pathogen reduction technology, while maintaining an adequate platelet inventory for our patients?

Published:2021-03-15 Issue:4 Volume:61 Page:1014-1022
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Nguyen Jennifer T.¹,Rioveros Jowin¹,Ziman Alyssa¹^ORCID,McGonigle Andrea M.¹^ORCID,Ward Dawn C.¹^ORCID

Affiliation:

1. Wing‐Kwai and Alice Lee‐Tsing Chung Transfusion Service, Department of Pathology and Laboratory Medicine David Geffen School of Medicine at UCLA Los Angeles California USA

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.16348

Reference10 articles.

1. Pathogen inactivation of platelets with a photochemical treatment with amotosalen HCl and ultraviolet light: process used in the SPRINT trial

2. Efforts Toward Elimination of Infectious Agents in Blood Products

3. Pathogen Reduction in Platelets: A Review of the Proposed Draft Guidance

4. Available from:https://www.cdc.gov/bloodsafety/bbp/bacterial‐contamination‐of‐platelets.html.

5. FDA‐CBER.Bacterial risk control strategies for blood collection establishments and transfusion services to enhance the safety and availability of platelet for transfusion.2018. [cited 2019 Sep 26]. Available from:https://www.fda.gov/media/123448/download.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transfusion outcomes between regular and low yield pathogen reduced platelets across different patient populations in a single institution;Transfusion;2022-08-04

2. Pathogen Reduction for Platelets—A Review of Recent Implementation Strategies;Pathogens;2022-01-24

3. Monte Carlo Simulation of Pathogen Reduced Platelet Production;Proceedings of the 12th International Conference on Simulation and Modeling Methodologies, Technologies and Applications;2022

4. Pathogen‐reduced platelets in pediatric and neonatal patients: Demographics, transfusion rates, and transfusion reactions;Transfusion;2021-08-27

5. A Platelet Inventory Management Assessment: Is a Pathogen Reduced Only Inventory Financially Feasible?;Transfusion Medicine Reviews;2021-07